"EC approves GSK’s RSV vaccine for adults aged 50-59 years" was originally created and published by Pharmaceutical Technology ...

GSK has revised its annual vaccine sales forecast following new guidance on RSV from the CDC. But new evidence offers new ...

If approved, the co-administration of Arexvy and Shingrix could provide a more convenient vaccination regimen for patients ...

LONDON, Sept 19 (Reuters) - The EU's drug regulator has approved Bavarian Nordic's (BAVA.CO), opens new tab mpox vaccine for ...

Sanofi said on Monday the U.S. Food and Drug Administration has approved a manufacturing line for its and partner AstraZeneca ...

Moderna Inc. (NASDAQ: MRNA) made headlines during the pandemic for its messenger ribonucleic acid (mRNA) technology used in ...

Bronchiolitis alarm in children, there is a life-saving drug but not all Regions can purchase it. The seasonal epidemic of ...

Focuses on ten product approvals through 2027Expects to submit next-generation COVID vaccine for approval in 2024Expects to submit flu/COVID ...

Nursing homes in New York are being urged to protect residents with the updated COVID-19 vaccine. The NYS Department of Health sent letters out to nursing facilities about ...

With the stock now more than cut in half from its 52-week high, the company recently laid out a plan for its business at its ...

Delta Air Lines said in an update on Thursday that capacity across the industry was also “moderating” and that its revenue ...

Moderna plans to cut $1.1bn in costs by 2027, pausing and scrapping several R&D programs. See why I think further downside ...